Clinical, Hematological and Pathological Profile of Pancytopenia
1 other identifier
observational
140
0 countries
N/A
Brief Summary
Describe clinical characteristic, peripheral blood parameters and bone marrow examination in pancytopenia patients and Analyze etiology of pancytopenia and study the outcomes regarding duration of hospital stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2026
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 20, 2026
CompletedFirst Posted
Study publicly available on registry
August 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2028
ExpectedAugust 25, 2026
August 1, 2026
Same day
August 20, 2026
August 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of underlying etiologies of pancytopenia
Percentage of study participants diagnosed with each etiology of pancytopenia based on clinical, hematological, and pathological evaluation
At the time of patient enrollment and initial diagnostic workup
Secondary Outcomes (2)
Frequency of clinical features and hematological parameters in pancytopenia patients
At baseline
Distribution of bone marrow pathological findings
At baseline
Study Arms (1)
Pancytopenia Cases
Patients presenting with clinical and laboratory features of pancytopenia who are admitted to or evaluated at Assiut University Hospitals. This group includes individuals undergoing routine clinical, hematological, and pathological assessments to identify the underlying causes of their condition.
Eligibility Criteria
The study population consists of patients of different age groups and both sexes who present with clinical manifestations and laboratory findings suggestive of pancytopenia, attending the inpatient departments or outpatient clinics at Assiut University Hospitals.
You may qualify if:
- Adults aged ≥ 18 years suffering from pancytopenia. Pancytopenia defined as a hematologic condition characterized by a decrease in all three peripheral blood cell lines. It is characterized by a hemoglobin value of less than 12 g/dL in women and 13 g/dL in men, platelets of less than 150,000 per mcL, and leukocytes of less than 4000 per ml (or absolute neutrophil count of less than 1800 per ml), (Chiravuri, Shalini, and Orlando De Jesus. "Pancytopenia.". StatPearls Publishing, 2023).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mai Mostafa mohamed kamal, Prof
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident physician
Study Record Dates
First Submitted
August 20, 2026
First Posted
August 25, 2026
Study Start
August 1, 2026
Primary Completion
August 1, 2026
Study Completion (Estimated)
October 1, 2028
Last Updated
August 25, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
The individual participant data will not be shared to protect patient privacy and maintain confidentiality in accordance with the institutional ethical guidelines of Assiut University. Only aggregate study results and statistical summaries will be available through publication.